NCT00265148 - Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 18, 2004

Primary Completion Date

July 10, 2008

Study Completion Date

July 10, 2008

Conditions

Alzheimer's Disease

Interventions

DRUG

Rosiglitazone

Extended Release Tablets

OTHER

Placebo

Placebo dummy to match

Trial Locations (15)

27705

GSK Investigational Site, Durham

48109

GSK Investigational Site, Ann Arbor

85006

GSK Investigational Site, Phoenix

85259

GSK Investigational Site, Scottsdale

85340

GSK Investigational Site, Litchfield Park

85351

GSK Investigational Site, Sun City

85724

GSK Investigational Site, Tucson

90024

GSK Investigational Site, Los Angeles

02478

GSK Investigational Site, Belmont

H3T 1E2

GSK Investigational Site, Montreal

H4H 1R3

GSK Investigational Site, Montreal

L9 7LJ

GSK Investigational Site, Liverpool

M20 3LJ

GSK Investigational Site, Manchester

SN1 4HZ

GSK Investigational Site, Swindon

SO30 3JB

GSK Investigational Site, West End, Southampton